S100 Calcium Binding Protein A6 Proteins (S100A6)

Human S100 Calcium Binding Protein A6 (S100A6) interaction partners

1. S100A6 is a potential risk marker for screening of cholangiocarcinoma.

2. The S100A6 interacts with FOR20 (show FOPNL Proteins) and related centrosomal proteins through a conserved N-terminal domain, suggesting a novel Ca(2 (show CA2 Proteins)+)-dependent regulation of centrosomal function.

3. REVIEW: summary of novel discoveries concerning S100A6 targets, its involvement in cellular signaling pathways, and presence in stem/progenitor cells, extracellular matrix and body fluids of diseased patients

4. Results showed that S100A6 was markedly up-regulated in nasopharyngeal carcinoma (NPC (show NPC1 Proteins)) tissues and cell lines and, may promote NPC (show NPC1 Proteins) development via the activation of p38/MAPK (show MAPK14 Proteins) signaling pathways.

5. As an intracellular protein (show CKAP2 Proteins), S100A6 has been implicated in the regulation of several cellular functions, such as proliferation, apoptosis, the cytoskeleton dynamics, and the cellular response to different stress factors. S100A6 can be secreted/released by certain cell types which points to extracellular effects of the protein. [review]

6. suppression of S100A6 expression with RNAi significantly decreased the expression levels of beta-catenin (show CTNNB1 Proteins), inhibited the growth and migration of eutopic endometrial stromal cells, and promoted their apoptosis.

7. Study reports the crystallographic structure of an S100-bound full-length RAGE (show AGER Proteins) ectodomain. The structure reveals a unique dimeric conformation of RAGE (show AGER Proteins), which appears suited for signal transduction, and shows that the S100A6 protein adopts a non-canonical homodimeric arrangement.

8. STAT1 (show STAT1 Proteins) suppression by S100A6 may represent a promising therapeutic target to facilitate reendothelialization in damaged vessels.

9. Our results indicate that serum levels of S100A2 (show S100A2 Proteins) and S100A6 are significantly elevated in early stage non-small cell lung cancer

10. findings strongly suggest that S100A6 may promote OS cell proliferation and OS tumor growth at least in part by facilitating cell cycle progression, preventing apoptosis, and inhibiting osteogenic differentiation

Pig (Porcine) S100 Calcium Binding Protein A6 (S100A6) interaction partners

1. S100A6 is upregulated during PRRSV infection; there is a putative NF-kappaB (show NFKB1 Proteins) binding site in the core promoter region

Mouse (Murine) S100 Calcium Binding Protein A6 (S100A6) interaction partners

1. our data provide the first evidence that S100A6 is a specific marker of neural stem cells and astrocyte precursors

2. new insight into the interaction between S100 proteins and CacyBP/SIP (show CACYBP Proteins)

3. the S100A6 protein is involved in multiple aspects of fibroblast physiology and that its presence ensures normal fibroblast proliferation and function

4. S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients

5. calcyclin has a role as an accessory protein involved in the cation-sensing pathway in osteoblasts

6. Calcyclin is one of the candidate proteins that plays a role in osteoblastogenesis in response to simvastatin, although the precise functions of calcyclin in osteoblast remain to be verified.

7. calcyclin gene expression was analyzed at three different stages in differentiating MyoD (show MYOD1 Proteins)(-)C2C12 myoblasts

8. Annexin XI (show ANXA11 Proteins) and calcyclin colocalize in proliferating cells of the embryonic mouse testis

9. S100A2 (show S100A2 Proteins) and S100A6 interact with another TPR (show GRID2 Proteins) protein Tom70 (show TOMM70A Proteins) and regulate the Tom70 (show TOMM70A Proteins)-ligand interaction in vitro

10. enhancement of S100A6 expression plays an important role in MLL-AF4-associated leukemogenesis